Given the possible role of thyroid antibodies (mostly TPO and thyroglobulin antibodies) in the development of ICIs-related thyroid dysfunction, the testing of TPO and thyroglobulin antibodies prior to ICIs initiation should be considered as positive antibodies may predict a higher likelihood of the development of thyroiditis during ICIs therapy. The gene discussed is TPO; the disease is thyroiditis.